XML 60 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 28, 2024
Share-based Payment Arrangement [Abstract]  
Schedule of Assumptions Used in Estimating Fair Value of Each Option Grant

    

December 28,

December 30,

December 31,

2024

2023

2022

Expected volatility

 

31.65

%  

31.97

%  

32.36

%

Risk-free interest rate

 

4.22

%  

4.21

%  

3.75

%

Expected life from vesting date

 

5.4 yrs

 

5.4 yrs

 

5.4 yrs

Dividend yield

 

0.88

%  

0.87

%  

1.10

%

Schedule of Activity of Stock Plans

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Shares

    

Price

    

Term

    

Value

Outstanding as of December 30, 2023

 

181,530

$

220.77

 

  

 

  

Granted

 

25,548

 

331.47

 

  

 

  

Exercised

 

(49,583)

 

164.38

 

  

 

  

Forfeited

 

(24,062)

 

268.84

 

  

 

  

Outstanding as of December 28, 2024

 

133,433

$

253.11

 

7.93

$

8,281

Options vested or expected to vest as of December 28, 2024

 

131,198

$

252.57

 

7.91

 

8,200

Options exercisable as of December 28, 2024

 

79,824

$

232.00

 

7.10

 

6,340

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Shares

    

Price

    

Term

    

Value

Outstanding as of December 31, 2022

 

195,690

$

214.62

 

  

 

  

Granted

 

43,340

 

226.55

 

  

 

  

Exercised

 

(39,055)

 

155.24

 

  

 

  

Forfeited

 

(18,445)

 

307.81

 

  

 

  

Outstanding as of December 30, 2023

 

181,530

$

220.77

 

7.99

$

5,992

Options vested or expected to vest as of December 30, 2023

 

178,820

$

220.31

 

7.96

 

5,975

Options exercisable as of December 30, 2023

 

116,545

$

203.78

 

7.13

 

5,576

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Shares

    

Price

    

Term

    

Value

Outstanding as of December 25, 2021

 

276,464

$

164.48

 

  

 

  

Granted

 

40,564

 

332.63

 

  

 

  

Exercised

 

(121,163)

 

139.89

 

  

 

  

Forfeited

 

(175)

 

104.47

 

  

 

  

Outstanding as of December 31, 2022

 

195,690

$

214.62

 

7.53

$

22,644

Options vested or expected to vest as of December 31, 2022

 

189,267

$

212.69

 

7.48

 

22,261

Options exercisable as of December 31, 2022

 

90,556

$

172.08

 

6.40

 

14,276

Schedule of Non-Vested Stock and Restricted Stock Units

    

Fiscal Year Ended

December 28,

December 30,

December 31,

2024

    

2023

    

2022

Restricted stock units granted

 

52,175

 

67,723

 

60,901

Weighted‑average per share price on grant date

$

295.84

$

233.96

$

313.75

Recognized compensation expense

$

17,141

$

22,478

$

22,664

Schedule of Share-based Payment Arrangement, Performance Shares, Outstanding Activity

    

Fiscal Year Ended

December 28,

December 30,

December 31,

2024

    

2023

    

2022

Shares granted

 

34,665

 

38,201

 

33,736

Weighted‑average per share price on grant date

$

234.52

$

299.20

$

215.15

Recognized compensation expense

$

10,476

$

13,054

$

16,066